Evidence map›Paper›PMID 41258016›Full record

ReviewNature protocols2026

Directional conjugation of monoclonal antibodies to nanoparticles using metal-free click chemistry.

Ananthakrishnan S Jeevarathinam, Mohammed R Kawelah, Sangheon Han, Brian J Grindel, Steven W Millward, Keith P Johnston, Konstantin V Sokolov

Abstract readReview
In one paragraph

Review in Nature protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ananthakrishnan S JeevarathinamDepartment of Imaging Physics, MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0003-1294-9451
Mohammed R KawelahMcKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.ORCID 0009-0003-0462-9383
Sangheon HanDepartment of Imaging Physics, MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0003-0626-3162
Brian J GrindelDepartment of Cancer System Imaging, MD Anderson Cancer Center, Houston, TX, USA.
Steven W MillwardDepartment of Cancer System Imaging, MD Anderson Cancer Center, Houston, TX, USA.
Keith P JohnstonMcKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.
Konstantin V SokolovDepartment of Imaging Physics, MD Anderson Cancer Center, Houston, TX, USA. ksokolov@mdanderson.org.ORCID 0000-0002-0198-2005

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
Molecular Photoacoustic Imaging for Diagnostics and Therapy MonitoringR01EB028762 · NIBIB · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BOUCHARD, RICHARD R. · 2020 to 2024
$3.1M
Super-Resolution OMX MicroscropeS10RR029552 · NCRR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ZAL, TOMASZ · 2011 to 2011
$1.0M
Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) RP190131Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) RP240311NCI NIH HHS P30 CA016672NCRR NIH HHS S10 RR029552NIBIB NIH HHS R01 EB028762NIH HHS P30CA016672U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB) R01EB028762Welch Foundation H-F-0037
6 · The paper itself

Abstract

Here, we describe a practical step-by-step protocol for directional conjugation of monoclonal antibodies to polymersome nanoparticles via the Fc antibody moiety using metal-free click chemistry. This Protocol Extension details procedures for synthesis, quality control and evaluation of nanoparticle-antibody conjugates. The synthesis includes three main stages: (i) a mild oxidation of the glycosyl moiety that is present only on the Fc region of the antibody to produce functional aldehyde groups; (ii) attachment of a heterobifunctional linker, aminooxy-PEG-dibenzocyclooctyne, to the aldehyde groups in the Fc moiety; and (iii) click conjugation of the PEG-linker-modified antibodies to nanoparticles with azide functional groups. This protocol enables covalent surface conjugation of monoclonal antibodies that inherently does not involve the antigen-binding Fab region, thus minimizing the impact of the conjugation on the avidity of antibodies. In contrast, conventional conjugation methods that use amine groups of antibodies for covalent immobilization result in a random antibody orientation that can lead to a loss of the antibody's binding efficiency. The entire conjugation protocol requires ~18 h. The nanoparticle-antibody conjugates synthesized using this method are expected to display a high molecular specificity toward epitopes of the conjugated antibodies while maintaining the physicochemical properties of the core nanoparticles. The protocol described here does not require any special expertise other than general laboratory training on equipment such as a centrifuge, ultraviolet-visible spectrophotometers, dynamic light scattering, ELISA plate readers and cell culturing.

Indexed as

Antibodies, MonoclonalClick ChemistryImmunoconjugatesNanoparticlesAntibodies, MonoclonalImmunoconjugates

Identifiers

PMID41258016
PMCPMC13633081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.